Ideal number of target lesions per organ to measure in metastatic colorectal cancer

Author：    

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.8, Iss.4, 2014-01, pp. : 1896-1900

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bevacizumab in the treatment of metastatic colorectal cancer

By Caprioni Francesco   Fornarini Giuseppe  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 141-148

Future Medicine

Access to resources Recommend Favorite

The Status of p53 in the Metastatic Progression of Colorectal Cancer

By Heide I.   Thiede C.   Sonntag T.   de Kant E.   Neubauer A.   Jonas S.   Peter F.J.   Neuhaus P.   Herrmann R.   Huhn D.   Rochlitz C.F.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1314-1322

Elsevier

Access to resources Recommend Favorite

Intermittent therapy in the palliative treatment of metastatic colorectal cancer

By Powell James   Adams Richard  

Colorectal Cancer, Vol. 2, Iss. 3, 2013-06 ,pp. : 219-232

Future Medicine

Access to resources Recommend Favorite

Laparoscopic Bowel Resection in the Setting of Metastatic Colorectal Cancer

By Lun Law Wai  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1424-1428

Springer Publishing Company

Access to resources Recommend Favorite

Recent Advances in the Systemic Therapy of Metastatic Colorectal Cancer

By Jefford Michael   Zalcberg John  

American Journal of Cancer, Vol. 4, Iss. 1, 2005-01 ,pp. : 15-34

Adis International

Access to resources Recommend Favorite